# Case Report: Full-house renal-limited lupus-like nephritis in pregnancy

**Authors:** Lucille Jane Wilkinson, Sally Stauder, Brady Culpepper, Jalal Ibrahim, Vivekanand Pantangi, Prathap Kumar Simhadri

PMC · DOI: 10.3389/fneph.2025.1593927 · Frontiers in Nephrology · 2025-06-30

## TL;DR

A pregnant woman with kidney disease resembling lupus but without systemic symptoms was successfully treated and delivered a healthy baby.

## Contribution

This case report adds new clinical insights into managing renal-limited lupus-like nephritis during pregnancy.

## Key findings

- The patient showed full-house staining in renal biopsy but was ANA-negative and had no systemic lupus symptoms.
- Treatment with steroids and cyclosporine led to improved kidney function and a successful pregnancy outcome.
- Six months postpartum, the patient had minimal proteinuria and no signs of systemic lupus erythematosus.

## Abstract

Lupus nephropathy is a common manifestation of systemic lupus erythematosus (SLE), with immune-mediated inflammatory damage to the glomerulus leading to acute kidney injury, chronic kidney disease, and end-stage renal disease. Occasionally, patients present with renal-limited lupus nephropathy with classic full-house staining on immunofluorescence and no signs of systemic lupus. Limited data are available on renal-limited “lupus-like nephropathy” in pregnancy. A 24-year-old G1P0 woman at 14 weeks of gestation was referred to nephrology for further evaluation of 8.4g proteinuria. She was found to be ANA negative with a decreased C1q level and a renal biopsy revealing membranous nephropathy. Immunofluorescence staining was positive for IgG, IgA, IgM, C3, and C1Q, consistent with full-house pattern. She was started on 500 mg pulse dose methylprednisolone for 3 days, which was gradually tapered to 5 mg daily, and cyclosporine 75 mg BID. She delivered a healthy baby via induction at 36 weeks. Six-month follow-up revealed 1g protein on 24-hour urine collection, normal C3/C4 levels, and no signs of SLE. This case report adds to the literature discussing renal-limited “lupus-like nephropathy” in pregnancy and helps guide further management of this condition.

## Linked entities

- **Proteins:** C1qa (complement component 1, q subcomponent, alpha polypeptide), IGG (Immunoglobulin G level), CD79A (CD79a molecule), CD40LG (CD40 ligand), C3 (complement C3), C1qa (complement component 1, q subcomponent, alpha polypeptide)
- **Chemicals:** methylprednisolone (PubChem CID 6741), cyclosporine (PubChem CID 5284373)
- **Diseases:** systemic lupus erythematosus (MONDO:0007915), membranous nephropathy (MONDO:0005376)

## Full-text entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, BTG3 (BTG anti-proliferation factor 3) [NCBI Gene 10950] {aka ANA, ANA/BTG3, APRO4, TOB5, TOB55, TOFA}
- **Diseases:** Limited (MESH:D045745), proteinuria (MESH:D011507), membranous nephropathy (MESH:D015433), nephritis (MESH:D009393), end-stage renal disease (MESH:D007676), acute kidney injury (MESH:D058186), chronic kidney disease (MESH:D051436), inflammatory damage (MESH:D018746), SLE (MESH:D008180)
- **Chemicals:** methylprednisolone (MESH:D008775), cyclosporine (MESH:D016572)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12256240/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12256240/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12256240/full.md

---
Source: https://tomesphere.com/paper/PMC12256240